Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Judith Regensteiner

Concepts (531)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intermittent Claudication
46
2022
118
5.220
 Why?
Diabetes Mellitus, Type 2
54
2024
2433
4.660
 Why?
Sex Characteristics
18
2024
722
3.560
 Why?
Peripheral Arterial Disease
24
2022
456
3.420
 Why?
Exercise
47
2024
1918
3.400
 Why?
Exercise Therapy
31
2022
413
3.070
 Why?
Peripheral Vascular Diseases
25
2011
102
2.610
 Why?
Sex Factors
20
2024
1951
2.360
 Why?
Oxygen Consumption
33
2021
671
2.180
 Why?
Cardiovascular Diseases
23
2024
2001
2.050
 Why?
Walking
23
2022
497
2.010
 Why?
Diabetes Mellitus
18
2024
996
1.970
 Why?
Women's Health
10
2024
361
1.810
 Why?
Biomedical Research
8
2024
633
1.540
 Why?
Exercise Test
38
2019
615
1.450
 Why?
Cardiology
6
2023
261
1.250
 Why?
Exercise Tolerance
15
2024
273
1.200
 Why?
American Heart Association
10
2019
297
1.170
 Why?
Quality of Life
18
2019
2688
1.140
 Why?
Research Personnel
5
2024
156
1.080
 Why?
Leg
13
2021
237
1.060
 Why?
Humans
184
2024
128495
0.980
 Why?
Mentoring
3
2022
130
0.920
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
73
0.900
 Why?
United States Food and Drug Administration
1
2024
198
0.860
 Why?
Diabetic Angiopathies
6
2017
261
0.860
 Why?
Vascular Stiffness
3
2023
463
0.850
 Why?
Female
106
2024
68266
0.850
 Why?
Male
101
2024
63043
0.820
 Why?
Muscle, Skeletal
14
2024
1624
0.820
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2024
411
0.800
 Why?
Community Health Services
2
2015
227
0.790
 Why?
Cardiovascular System
5
2023
137
0.780
 Why?
Diabetic Cardiomyopathies
3
2016
34
0.780
 Why?
Education, Medical
3
2020
244
0.770
 Why?
Periodicals as Topic
1
2024
203
0.760
 Why?
Insulin Resistance
12
2024
1164
0.720
 Why?
Lower Extremity
9
2019
402
0.700
 Why?
Arterial Occlusive Diseases
7
2015
80
0.680
 Why?
Interdisciplinary Research
1
2020
26
0.670
 Why?
Aged
57
2024
21974
0.670
 Why?
Middle Aged
73
2024
30921
0.660
 Why?
Endothelium, Vascular
6
2021
844
0.650
 Why?
Cardiorespiratory Fitness
2
2019
48
0.650
 Why?
Obesity
19
2023
2864
0.640
 Why?
Sitagliptin Phosphate
1
2019
31
0.630
 Why?
Diastole
1
2019
148
0.620
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2019
45
0.610
 Why?
Surveys and Questionnaires
23
2018
5371
0.610
 Why?
United States
37
2024
13840
0.600
 Why?
Gender Identity
1
2019
121
0.580
 Why?
Hypoglycemic Agents
9
2021
1217
0.580
 Why?
Physical Fitness
9
2016
203
0.580
 Why?
Metabolomics
2
2020
602
0.570
 Why?
Brachial Artery
6
2015
185
0.560
 Why?
Health Status
4
2020
747
0.560
 Why?
Mitochondria, Muscle
4
2024
111
0.550
 Why?
Hypertension
6
2022
1236
0.550
 Why?
Physical Exertion
7
2009
207
0.540
 Why?
Blood Pressure
12
2021
1712
0.530
 Why?
Curriculum
2
2020
910
0.530
 Why?
Venoms
1
2016
29
0.530
 Why?
Vasodilator Agents
4
2010
324
0.520
 Why?
Biomarkers
6
2024
3893
0.500
 Why?
Research Design
5
2024
1036
0.470
 Why?
Cardiac Rehabilitation
3
2019
34
0.470
 Why?
Life Style
9
2018
459
0.460
 Why?
Sleep
1
2020
682
0.450
 Why?
National Institutes of Health (U.S.)
4
2023
122
0.450
 Why?
Arteriosclerosis
5
2002
88
0.440
 Why?
Physicians
5
2024
863
0.430
 Why?
Ventricular Dysfunction, Left
1
2016
383
0.420
 Why?
Faculty, Medical
6
2024
263
0.420
 Why?
Home Care Services
4
2019
244
0.410
 Why?
Risk Factors
29
2022
9737
0.410
 Why?
Microcirculation
4
2017
137
0.410
 Why?
Diabetes Mellitus, Type 1
9
2024
3626
0.410
 Why?
Mentors
4
2022
178
0.390
 Why?
Advisory Committees
5
2019
214
0.390
 Why?
Longevity
3
2024
150
0.390
 Why?
Blood Flow Velocity
4
2009
404
0.380
 Why?
Adult
40
2024
35299
0.360
 Why?
Peptides
1
2016
915
0.360
 Why?
Weight Loss
6
2016
727
0.350
 Why?
Treatment Outcome
24
2022
10162
0.350
 Why?
Disability Evaluation
2
2011
285
0.350
 Why?
Ankle
3
2008
62
0.340
 Why?
Gait
2
2006
277
0.340
 Why?
Regional Blood Flow
11
2020
458
0.320
 Why?
Tetrazoles
3
2006
37
0.320
 Why?
Cardiac Output, Low
1
2009
66
0.310
 Why?
Physical Endurance
3
2011
262
0.310
 Why?
Double-Blind Method
8
2019
1856
0.310
 Why?
Thiazolidinediones
3
2010
137
0.300
 Why?
Oxygen
4
2018
901
0.300
 Why?
Research Support as Topic
2
2020
111
0.300
 Why?
Recovery of Function
9
2019
633
0.300
 Why?
Cost of Illness
3
2018
278
0.300
 Why?
Fear
1
2011
347
0.290
 Why?
Oxidative Phosphorylation
2
2019
186
0.280
 Why?
Follow-Up Studies
9
2024
4874
0.280
 Why?
Glucagon-Like Peptide 1
2
2020
112
0.280
 Why?
Hematologic Agents
1
2006
1
0.270
 Why?
Activities of Daily Living
5
2021
383
0.270
 Why?
Blood Glucose
10
2024
2092
0.270
 Why?
Perception
1
2009
336
0.270
 Why?
Caregivers
3
2024
813
0.270
 Why?
Medicare
2
2022
719
0.260
 Why?
Stents
6
2015
504
0.260
 Why?
Disease Management
4
2017
584
0.250
 Why?
Motor Activity
5
2012
669
0.250
 Why?
Vascular Diseases
4
2000
232
0.240
 Why?
Foundations
2
2018
24
0.240
 Why?
Feasibility Studies
2
2022
863
0.240
 Why?
Vascular Surgical Procedures
5
2009
294
0.240
 Why?
Societies, Medical
3
2017
744
0.240
 Why?
Pharmacovigilance
1
2024
21
0.240
 Why?
Interdisciplinary Studies
2
2017
28
0.230
 Why?
Echocardiography
4
2018
624
0.230
 Why?
Troponin
1
2024
50
0.230
 Why?
Vasodilation
3
2015
461
0.230
 Why?
Troponin T
1
2024
57
0.230
 Why?
Respiration
3
1990
190
0.220
 Why?
Insulin
5
2020
2316
0.220
 Why?
Fibrinolysis
2
2003
137
0.220
 Why?
Troponin I
1
2024
75
0.220
 Why?
Heart Rate
6
2015
798
0.220
 Why?
Overweight
6
2023
523
0.220
 Why?
Chest Pain
1
2024
89
0.220
 Why?
Medroxyprogesterone
4
1991
10
0.210
 Why?
Kinetics
5
2015
1623
0.210
 Why?
Pulse Wave Analysis
3
2023
246
0.210
 Why?
Lung Diseases
3
2019
715
0.210
 Why?
Muscles
7
1994
322
0.210
 Why?
Minority Groups
2
2022
250
0.210
 Why?
Iliac Artery
2
2014
54
0.210
 Why?
Polyhydroxyethyl Methacrylate
1
2002
10
0.210
 Why?
Financing, Organized
2
2020
30
0.210
 Why?
Financial Management
1
2022
15
0.200
 Why?
Predictive Value of Tests
5
2017
1938
0.200
 Why?
Phosphodiesterase Inhibitors
1
2002
85
0.200
 Why?
Vitamin E
1
2003
120
0.200
 Why?
Glucose Intolerance
1
2024
142
0.200
 Why?
Practice Guidelines as Topic
4
2019
1490
0.200
 Why?
Orthopedics
1
2024
135
0.200
 Why?
Ascorbic Acid
1
2003
119
0.190
 Why?
Endovascular Procedures
2
2018
302
0.190
 Why?
Estrogens, Conjugated (USP)
3
1991
46
0.190
 Why?
Academic Medical Centers
3
2020
480
0.190
 Why?
Congresses as Topic
2
2020
211
0.180
 Why?
Qualitative Research
3
2024
1227
0.180
 Why?
Organizational Innovation
2
2020
138
0.180
 Why?
Arginine
1
2003
260
0.180
 Why?
Placebos
3
2019
201
0.180
 Why?
Adiponectin
2
2016
234
0.180
 Why?
Interdisciplinary Communication
2
2020
185
0.180
 Why?
Severity of Illness Index
4
2009
2719
0.180
 Why?
Sulfonylurea Compounds
2
2019
46
0.180
 Why?
Echocardiography, Doppler
3
2016
108
0.180
 Why?
Sex Distribution
2
2020
358
0.170
 Why?
Precision Medicine
2
2024
386
0.170
 Why?
Neovascularization, Physiologic
2
2012
172
0.170
 Why?
Time Factors
11
2018
6505
0.170
 Why?
Patient Compliance
4
2015
560
0.170
 Why?
Cardiovascular Agents
2
2014
152
0.170
 Why?
Hemodynamics
6
2009
1077
0.160
 Why?
Clinical Trials as Topic
6
2019
1003
0.160
 Why?
Arteries
3
2016
261
0.160
 Why?
Forearm
2
2015
117
0.160
 Why?
Randomized Controlled Trials as Topic
7
2006
1358
0.160
 Why?
Case-Control Studies
7
2024
3339
0.160
 Why?
Pediatric Obesity
2
2017
570
0.160
 Why?
Body Composition
5
2014
644
0.160
 Why?
Body Mass Index
9
2017
2263
0.150
 Why?
Telerehabilitation
1
2019
36
0.150
 Why?
Adolescent
12
2022
20304
0.150
 Why?
Cross-Sectional Studies
8
2014
5045
0.150
 Why?
Cause of Death
1
2020
392
0.150
 Why?
Burnout, Professional
1
2024
407
0.150
 Why?
Leadership
2
2020
352
0.150
 Why?
Magnetic Resonance Spectroscopy
2
2024
510
0.150
 Why?
Women's Rights
1
2017
4
0.150
 Why?
Diabetes Complications
4
2010
223
0.140
 Why?
Aged, 80 and over
9
2012
7057
0.140
 Why?
Pentoxifylline
3
2006
23
0.140
 Why?
Interviews as Topic
4
2024
715
0.140
 Why?
Circadian Rhythm
2
2020
412
0.140
 Why?
Resistance Training
1
2020
151
0.140
 Why?
Health Status Indicators
4
2015
167
0.140
 Why?
Sexism
1
2018
55
0.140
 Why?
Program Development
1
2019
357
0.140
 Why?
Death, Sudden, Cardiac
1
2018
179
0.140
 Why?
Heart Diseases
2
2019
347
0.140
 Why?
Capillaries
3
2012
91
0.130
 Why?
Colorado
9
2017
4399
0.130
 Why?
Ankle Brachial Index
2
2014
36
0.130
 Why?
Microvessels
1
2017
79
0.130
 Why?
Faculty
1
2017
135
0.120
 Why?
Glucose Tolerance Test
4
2024
356
0.120
 Why?
Leptin
1
2017
218
0.120
 Why?
Ischemia
1
2019
394
0.120
 Why?
Reference Values
4
2007
780
0.120
 Why?
Blood Vessels
1
2017
183
0.120
 Why?
Needs Assessment
1
2018
356
0.120
 Why?
Plethysmography
3
2011
107
0.120
 Why?
Health Status Disparities
1
2018
255
0.120
 Why?
Intention to Treat Analysis
1
2015
68
0.120
 Why?
Adiposity
2
2017
504
0.120
 Why?
Program Evaluation
2
2020
872
0.120
 Why?
Myocardium
1
2020
968
0.120
 Why?
Pilot Projects
2
2015
1568
0.120
 Why?
Ventricular Function
1
2015
61
0.120
 Why?
Cardiac Output
1
2015
154
0.120
 Why?
Oxidative Stress
1
2021
1191
0.110
 Why?
Physical Education and Training
1
1994
75
0.110
 Why?
Endothelium
1
2015
107
0.110
 Why?
Arterial Pressure
1
2015
117
0.110
 Why?
Patient Selection
4
2019
661
0.110
 Why?
Healthy Volunteers
1
2015
199
0.110
 Why?
Peripheral Nervous System Diseases
1
1995
121
0.110
 Why?
Health Care Costs
2
2014
366
0.110
 Why?
Hypoxia
3
1990
1035
0.110
 Why?
Hyperlipidemias
3
2004
125
0.110
 Why?
Diagnostic Self Evaluation
1
2013
22
0.110
 Why?
Menopause
3
1991
291
0.110
 Why?
Angioplasty
2
2009
47
0.110
 Why?
Aortic Diseases
1
2014
114
0.110
 Why?
Reaction Time
1
2015
407
0.100
 Why?
Diet, Reducing
1
2013
86
0.100
 Why?
Carnitine
5
2001
76
0.100
 Why?
Ventricular Function, Left
1
2016
524
0.100
 Why?
Students, Medical
1
2017
315
0.100
 Why?
Retrospective Studies
4
2024
14471
0.100
 Why?
Diabetic Nephropathies
2
2014
279
0.100
 Why?
Smoking
6
2010
1459
0.100
 Why?
Capacity Building
1
2012
58
0.100
 Why?
Kidney
2
2021
1310
0.100
 Why?
Premenopause
2
2003
121
0.100
 Why?
Counseling
1
2015
384
0.090
 Why?
Clinical Protocols
1
1993
254
0.090
 Why?
Myocardial Revascularization
1
2011
71
0.090
 Why?
Health Promotion
1
2017
716
0.090
 Why?
Heart Ventricles
1
2016
767
0.090
 Why?
Linear Models
2
2014
816
0.090
 Why?
Research Report
1
2011
75
0.090
 Why?
Benchmarking
1
2012
175
0.090
 Why?
Comorbidity
4
2021
1541
0.090
 Why?
Sickness Impact Profile
1
2011
55
0.090
 Why?
Hyperemia
1
2011
46
0.090
 Why?
Hemoglobins
2
2017
337
0.090
 Why?
Self Concept
1
2012
241
0.090
 Why?
Fatty Acids, Nonesterified
2
2009
159
0.090
 Why?
Consensus
3
2019
610
0.090
 Why?
Coronary Disease
4
2004
384
0.080
 Why?
Lovastatin
1
2010
26
0.080
 Why?
Niacin
1
2010
19
0.080
 Why?
Young Adult
6
2024
12349
0.080
 Why?
Affect
1
2012
284
0.080
 Why?
Atherosclerosis
2
2011
403
0.080
 Why?
Hypertrophy, Left Ventricular
2
2009
126
0.080
 Why?
C-Reactive Protein
2
2009
398
0.080
 Why?
Platelet Aggregation Inhibitors
3
2002
439
0.080
 Why?
Gonadal Steroid Hormones
1
1990
129
0.080
 Why?
Body Fat Distribution
1
2009
49
0.080
 Why?
Vascular Endothelial Growth Factor A
1
2012
503
0.080
 Why?
Heart Function Tests
1
2009
59
0.080
 Why?
Hospitalization
1
2018
2069
0.080
 Why?
Pulmonary Wedge Pressure
1
2009
66
0.080
 Why?
Aorta
1
2011
408
0.080
 Why?
Hyperinsulinism
2
2010
119
0.080
 Why?
Thinness
1
2009
89
0.080
 Why?
Heart Failure
3
2018
2145
0.080
 Why?
Psychometrics
1
2012
682
0.080
 Why?
Age Factors
4
2021
3122
0.080
 Why?
Fasting
2
2005
264
0.080
 Why?
Analysis of Variance
4
2012
1273
0.080
 Why?
Perfusion
1
2009
188
0.070
 Why?
Puberty
1
2009
143
0.070
 Why?
Mitochondria
1
2014
855
0.070
 Why?
Cost-Benefit Analysis
4
2014
569
0.070
 Why?
Angina Pectoris
1
2008
67
0.070
 Why?
Myoglobin
1
2007
13
0.070
 Why?
Aging
1
2018
1755
0.070
 Why?
Inflammation
3
2009
2666
0.070
 Why?
Leisure Activities
2
2006
29
0.070
 Why?
Awareness
1
2008
99
0.070
 Why?
Prospective Studies
8
2019
7069
0.070
 Why?
Prevalence
3
2019
2553
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2008
1276
0.070
 Why?
Regression Analysis
5
1998
982
0.060
 Why?
Dyspnea
1
2008
239
0.060
 Why?
Chronic Disease
2
2023
1692
0.060
 Why?
Glycation End Products, Advanced
1
2006
76
0.060
 Why?
Neoplasms
2
2010
2463
0.060
 Why?
Blood Viscosity
2
1995
16
0.060
 Why?
Lipids
1
2009
621
0.060
 Why?
Metformin
2
2010
314
0.060
 Why?
Interleukin-6
1
2009
715
0.060
 Why?
Pulmonary Circulation
1
2007
417
0.060
 Why?
Multicenter Studies as Topic
2
2004
286
0.060
 Why?
Glucose Clamp Technique
1
2005
194
0.060
 Why?
Hematocrit
2
1995
93
0.060
 Why?
Animals
5
2018
34647
0.060
 Why?
Sulfonic Acids
1
2004
13
0.060
 Why?
Guilt
1
2024
12
0.060
 Why?
Population Dynamics
1
1985
136
0.060
 Why?
Work-Life Balance
1
2024
18
0.060
 Why?
Nutrition Surveys
1
2006
261
0.060
 Why?
Estrogens
2
2010
342
0.060
 Why?
Cohort Studies
3
2016
5402
0.060
 Why?
Incidence
3
2019
2638
0.060
 Why?
Acetates
1
2004
99
0.060
 Why?
Health Maintenance Organizations
1
2004
97
0.060
 Why?
Dietary Carbohydrates
1
2004
150
0.050
 Why?
Body Weight
2
2006
933
0.050
 Why?
Biopsy
3
2012
1079
0.050
 Why?
Physicians, Women
1
2024
70
0.050
 Why?
Mitochondrial Diseases
1
2024
90
0.050
 Why?
Intracranial Arterial Diseases
1
2002
8
0.050
 Why?
Genetic Vectors
1
2004
311
0.050
 Why?
Child
5
2017
20805
0.050
 Why?
Dietary Fats
1
2004
301
0.050
 Why?
Glycolysis
1
2024
293
0.050
 Why?
Musculoskeletal Diseases
1
2003
69
0.050
 Why?
Serum Globulins
1
2002
5
0.050
 Why?
Neovascularization, Pathologic
1
2004
290
0.050
 Why?
Lung
1
2015
3748
0.050
 Why?
Genetic Therapy
1
2004
292
0.050
 Why?
Prognosis
2
2010
3780
0.050
 Why?
Ambulatory Care
2
2014
504
0.050
 Why?
Psychomotor Performance
1
2004
312
0.050
 Why?
Plasminogen Activator Inhibitor 1
1
2002
84
0.050
 Why?
Alcohol Drinking
2
2010
758
0.050
 Why?
Pelvis
1
2002
103
0.050
 Why?
Single-Blind Method
2
2013
268
0.050
 Why?
Adipose Tissue
1
2005
589
0.050
 Why?
Proteinuria
1
2001
88
0.050
 Why?
Fibroblast Growth Factor 2
1
2001
85
0.050
 Why?
Diet
2
2010
1204
0.050
 Why?
Homocysteine
1
2002
149
0.050
 Why?
Patient Satisfaction
2
2002
626
0.050
 Why?
Enzyme Inhibitors
1
2004
813
0.050
 Why?
Physical Examination
1
2002
233
0.050
 Why?
Fibrinogen
1
2002
164
0.050
 Why?
Meta-Analysis as Topic
1
2002
169
0.040
 Why?
Aorta, Thoracic
1
2023
260
0.040
 Why?
Altitude
1
1985
452
0.040
 Why?
Cardiovascular Surgical Procedures
1
2000
28
0.040
 Why?
Multivariate Analysis
3
2014
1499
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
198
0.040
 Why?
Administration, Oral
1
2003
767
0.040
 Why?
Cholesterol, LDL
2
2014
357
0.040
 Why?
Myocardial Ischemia
1
2002
247
0.040
 Why?
Tissue Plasminogen Activator
1
2002
222
0.040
 Why?
Carrier Proteins
1
2004
732
0.040
 Why?
Internal Medicine
1
2002
246
0.040
 Why?
Medroxyprogesterone Acetate
2
1990
35
0.040
 Why?
Specialties, Surgical
1
2000
73
0.040
 Why?
Organization and Administration
1
2019
9
0.040
 Why?
Pregnancy
3
2020
6373
0.040
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
91
0.040
 Why?
Femoral Artery
2
2011
170
0.040
 Why?
Rural Population
2
1995
517
0.040
 Why?
Sports Medicine
2
2010
108
0.040
 Why?
Asia
1
2018
58
0.040
 Why?
Risk Adjustment
1
2019
79
0.040
 Why?
Apoptosis
1
2007
2437
0.040
 Why?
Densitometry
1
1998
34
0.040
 Why?
Social Stigma
1
2020
117
0.040
 Why?
Lactic Acid
2
1998
294
0.040
 Why?
Patient Outcome Assessment
1
2019
125
0.040
 Why?
Hypercapnia
2
1989
49
0.040
 Why?
Public Health
1
2023
482
0.040
 Why?
Coronary Vessels
1
2020
236
0.040
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2001
335
0.040
 Why?
Walking Speed
1
2018
44
0.040
 Why?
Secondary Prevention
1
2019
219
0.040
 Why?
Cell Respiration
1
2018
98
0.040
 Why?
Autonomic Nervous System
1
1998
75
0.040
 Why?
Depression
1
2007
1292
0.040
 Why?
Walk Test
1
2018
70
0.040
 Why?
Hand Strength
1
2018
111
0.040
 Why?
Smoking Cessation
1
2002
407
0.040
 Why?
Betacoronavirus
1
2020
247
0.040
 Why?
Neural Conduction
2
1995
82
0.040
 Why?
Drug Therapy, Combination
2
2010
1016
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2017
62
0.040
 Why?
Capillary Resistance
1
2017
5
0.040
 Why?
Acute Disease
1
2020
965
0.040
 Why?
Career Choice
1
2019
207
0.040
 Why?
Reproducibility of Results
2
2013
3021
0.030
 Why?
Oxyhemoglobins
1
2017
21
0.030
 Why?
Family Practice
1
2001
434
0.030
 Why?
Caloric Restriction
1
2018
108
0.030
 Why?
Weight Reduction Programs
1
2018
111
0.030
 Why?
Spectroscopy, Near-Infrared
1
2017
48
0.030
 Why?
Canada
1
2018
346
0.030
 Why?
Sensitivity and Specificity
2
2013
1817
0.030
 Why?
Forecasting
2
2000
356
0.030
 Why?
Heart
1
2020
637
0.030
 Why?
Bicycling
1
2017
116
0.030
 Why?
Social Support
1
2020
589
0.030
 Why?
Vascular Resistance
1
2017
367
0.030
 Why?
Stroke Volume
1
2018
589
0.030
 Why?
Pneumonia, Viral
1
2020
337
0.030
 Why?
Coronavirus Infections
1
2020
333
0.030
 Why?
Matched-Pair Analysis
1
1995
40
0.030
 Why?
Energy Intake
3
2006
454
0.030
 Why?
Absorptiometry, Photon
1
2016
248
0.030
 Why?
Risk
1
2017
853
0.030
 Why?
Electrophysiology
1
1995
205
0.030
 Why?
Cystatin C
1
2014
65
0.030
 Why?
Vascular Patency
1
2014
102
0.030
 Why?
Models, Economic
1
2014
53
0.030
 Why?
Quality-Adjusted Life Years
1
2014
106
0.030
 Why?
Patient Education as Topic
1
2019
734
0.030
 Why?
Life Expectancy
1
2014
61
0.030
 Why?
Phosphorus
1
2014
93
0.030
 Why?
Databases, Factual
2
2011
1267
0.030
 Why?
Stress, Mechanical
1
2016
463
0.030
 Why?
Hospital Costs
1
2014
114
0.030
 Why?
Constriction, Pathologic
1
2014
228
0.030
 Why?
Drug Costs
1
2014
100
0.030
 Why?
Health Behavior
1
2019
740
0.030
 Why?
Cyclic AMP Response Element-Binding Protein
1
2014
141
0.030
 Why?
Health Education
1
2016
332
0.030
 Why?
Nitric Oxide Synthase Type III
1
2014
197
0.030
 Why?
Collateral Circulation
2
2003
18
0.030
 Why?
Carotid Stenosis
1
2014
85
0.030
 Why?
Biomechanical Phenomena
1
2016
763
0.030
 Why?
Internship and Residency
1
2002
1045
0.030
 Why?
Creatinine
1
2014
480
0.030
 Why?
Administrative Personnel
1
2012
28
0.030
 Why?
Blood Vessel Prosthesis
1
2013
124
0.020
 Why?
Evidence-Based Medicine
1
2016
712
0.020
 Why?
Statistics as Topic
1
2013
304
0.020
 Why?
Waist Circumference
1
2012
138
0.020
 Why?
Treatment Failure
1
2013
338
0.020
 Why?
Health Planning
1
1992
47
0.020
 Why?
Pandemics
1
2020
1477
0.020
 Why?
North Carolina
1
2012
98
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
66
0.020
 Why?
Behavior Therapy
1
2014
236
0.020
 Why?
Cerebrovascular Disorders
1
1992
90
0.020
 Why?
Muscle Strength
1
2014
304
0.020
 Why?
Muscle Contraction
1
2014
424
0.020
 Why?
Popliteal Artery
1
2011
58
0.020
 Why?
Estrone
1
1991
36
0.020
 Why?
Radioimmunoassay
1
1991
169
0.020
 Why?
Kaplan-Meier Estimate
1
2013
856
0.020
 Why?
Glomerular Filtration Rate
1
2014
684
0.020
 Why?
Follicular Phase
1
1990
38
0.020
 Why?
C-Peptide
1
1991
163
0.020
 Why?
Metabolism
1
1990
38
0.020
 Why?
Luteal Phase
1
1990
44
0.020
 Why?
Incretins
1
2010
18
0.020
 Why?
Receptor, IGF Type 1
1
2010
65
0.020
 Why?
Actigraphy
1
2010
97
0.020
 Why?
Adaptation, Physiological
1
2014
513
0.020
 Why?
Receptor, Insulin
1
2010
99
0.020
 Why?
Acetylcarnitine
1
1989
4
0.020
 Why?
Health Services Research
1
2012
389
0.020
 Why?
Progesterone
1
1991
242
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2012
820
0.020
 Why?
Percutaneous Coronary Intervention
1
2015
466
0.020
 Why?
Attitude of Health Personnel
1
2017
1090
0.020
 Why?
Delayed-Action Preparations
1
2010
170
0.020
 Why?
Risk Assessment
2
2009
3232
0.020
 Why?
Energy Metabolism
3
2006
833
0.020
 Why?
Respiration Disorders
1
1989
72
0.020
 Why?
Partial Pressure
1
1988
29
0.020
 Why?
Estradiol
1
1991
489
0.020
 Why?
Tidal Volume
1
1988
82
0.020
 Why?
Drug Interactions
1
1989
361
0.020
 Why?
Ankle Joint
1
2008
104
0.020
 Why?
Risk Reduction Behavior
1
2009
208
0.020
 Why?
Pain
1
1993
751
0.020
 Why?
Fluoroquinolones
1
2007
45
0.020
 Why?
Testosterone
1
2010
370
0.020
 Why?
Caspase 3
1
2007
230
0.020
 Why?
Hyperglycemia
1
2010
326
0.020
 Why?
Longitudinal Studies
1
2014
2710
0.020
 Why?
Models, Cardiovascular
1
2007
190
0.020
 Why?
Receptor for Advanced Glycation End Products
1
2006
31
0.020
 Why?
Enzyme Activation
1
2007
797
0.020
 Why?
Income
1
2007
189
0.020
 Why?
Sleep Wake Disorders
1
1989
250
0.020
 Why?
Carbon Dioxide
1
1988
258
0.020
 Why?
Sterol O-Acyltransferase
1
2004
5
0.010
 Why?
Receptors, Immunologic
1
2006
216
0.010
 Why?
Acetamides
1
2004
36
0.010
 Why?
Case Management
1
2004
63
0.010
 Why?
Age Distribution
1
2004
373
0.010
 Why?
Cell Adhesion Molecules
1
2004
173
0.010
 Why?
Gene Transfer Techniques
1
2004
162
0.010
 Why?
Calcium-Binding Proteins
1
2004
209
0.010
 Why?
Cognition Disorders
1
2007
498
0.010
 Why?
Magnetic Resonance Imaging
1
2014
3387
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2004
372
0.010
 Why?
Cytokines
1
2010
1994
0.010
 Why?
Endpoint Determination
1
2001
76
0.010
 Why?
Lactates
2
1992
83
0.010
 Why?
Ultrasonography, Doppler
1
2001
118
0.010
 Why?
Sulfonamides
1
2004
495
0.010
 Why?
Algorithms
1
2008
1614
0.010
 Why?
Wound Healing
1
2003
301
0.010
 Why?
Attitude
1
2002
251
0.010
 Why?
World Health Organization
1
2000
110
0.010
 Why?
Artificial Limbs
1
2003
170
0.010
 Why?
Costs and Cost Analysis
1
2000
200
0.010
 Why?
Logistic Models
1
2004
1980
0.010
 Why?
Models, Biological
1
2006
1698
0.010
 Why?
Indians, North American
1
2004
599
0.010
 Why?
Interpersonal Relations
1
2002
390
0.010
 Why?
Socioeconomic Factors
1
2002
1212
0.010
 Why?
Diabetic Neuropathies
1
1998
86
0.010
 Why?
Models, Theoretical
1
2000
542
0.010
 Why?
Diabetic Retinopathy
1
1998
172
0.010
 Why?
Muscle Fibers, Skeletal
1
1996
190
0.010
 Why?
Rehabilitation
1
1992
16
0.010
 Why?
Cholesterol, HDL
1
1991
203
0.010
 Why?
Electromyography
1
1992
381
0.010
 Why?
Hydroxybutyrates
1
1989
11
0.010
 Why?
3-Hydroxybutyric Acid
1
1989
14
0.010
 Why?
Blood Gas Analysis
1
1989
71
0.010
 Why?
Nervous System Diseases
1
1992
252
0.000
 Why?
Ultrasonics
1
1989
47
0.000
 Why?
Action Potentials
1
1992
469
0.000
 Why?
Sleep Apnea Syndromes
1
1989
80
0.000
 Why?
Drug Combinations
1
1989
324
0.000
 Why?
Mice
1
1989
16620
0.000
 Why?
Regensteiner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (531) concept(s)
_
Co-Authors Expand Description
See all (52) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)